Wet age-related macular degeneration
In neovascular or ‘wet’ AMD, abnormal leaking vessels grow beneath or within the retina. Fluid and blood can damage the macula and reduce central vision.
Intravitreal injection is an established outpatient treatment for conditions in which fluid or abnormal vessels threaten the macula and central vision.
IVOM stands for intravitreal injection. A very fine needle delivers medicine into the vitreous, the gel-like space inside the eye in front of the retina.
Tablets, eye drops and ointments often cannot deliver enough medicine to the retina. Injecting into the vitreous brings the medicine close to the affected macula. Treatment takes place on an outpatient basis, with local anaesthetic eye drops and strictly sterile conditions.
An intravitreal injection is not an injection ‘behind the eye’ and usually does not require general anaesthesia. Giving the medicine takes only a few seconds. Preparation, disinfection and checks take considerably longer because safety and hygiene are essential.
Fluid in the macula is a finding, not a diagnosis by itself. The underlying disease determines the medicine, treatment goals and follow-up.
In neovascular or ‘wet’ AMD, abnormal leaking vessels grow beneath or within the retina. Fluid and blood can damage the macula and reduce central vision.
Retinal vessels damaged by diabetes can leak fluid. If swelling affects the area of sharpest vision, reading, recognising faces and driving may become much harder.
A blocked retinal vein causes blood to back up. Bleeding and fluid in the macula can cause a sudden or increasing loss of vision.
Intravitreal treatment may also help with abnormal new blood vessels caused by other conditions, such as high myopia. The precise diagnosis determines whether it is appropriate.
We choose the medicine and schedule according to diagnosis, disease activity, previous response and personal risks.
In many retinal diseases, signalling proteins such as VEGF play an important role. They encourage abnormal blood vessels to grow and make vessel walls more permeable. Medicines that block these signals can help reduce fluid build-up and swelling.
They are mainly used for wet AMD, diabetic macular oedema, swelling after retinal vein occlusion and certain other forms of abnormal vessel growth.
Steroids mainly act on inflammation and increased leakage from blood vessels. For some conditions, they can be given as a longer-lasting implant, for example when diabetic macular oedema has not responded sufficiently to previous treatment.
Steroids can raise eye pressure and contribute to cataract formation. We therefore pay particular attention to the lens, glaucoma risk and regular pressure checks.
We agree the appropriate medicine during your consultation. Do not change it, skip doses or alter the intervals on your own.
One image is rarely enough. We assess visual function, retinal examination, OCT and changes over time together.
We assess central vision and ask about distorted lines, spots or changes in the perceived size of objects.
With the pupils dilated, we assess the macula, retinal vessels, bleeding and other changes at the back of the eye.
OCT shows the individual retinal layers, making fluid, swelling and macular changes clearly visible and comparable over time.
Fluorescein angiography or additional OCT angiography can show leaking vessels and abnormal new vessel growth.
We pay particular attention to eye pressure, the lens and individual risks if steroid treatment is being considered.
Planning includes existing conditions, allergies, previous eye surgery and all medication. Never stop blood thinners on your own.
How long the effect lasts depends on the medicine and condition. Retinal diseases can become active again and need long-term monitoring.
Treatment often starts with several injections at set intervals. The number depends on the condition, approved medicine and your examination findings.
Visual acuity, retinal examination and especially OCT show whether fluid is decreasing, the macula stays dry or disease activity has returned.
If your condition allows, we can gradually extend the time between treatments and shorten it again if disease activity returns. Other regimens give treatment only when a need is confirmed.
Do not postpone or stop a planned course of treatment without consulting us. Even if your vision seems stable, OCT can reveal renewed disease activity before you notice a change.
Treatment is minimally invasive. Sterile procedures before and after the injection are an essential part of keeping it safe.
We check your identity, the eye being treated, the medicine and consent. Tell us about current infections, new symptoms or changes to your medication.
Anaesthetic drops numb the eye’s surface. The eyelids, lashes, skin and conjunctiva are carefully disinfected, and a small holder keeps the eye open.
A very fine needle passes through the white of the eye to deliver medicine into the vitreous. The injection itself takes only a few seconds.
Immediately afterwards, we check whether you can see light or fingers. Further checks may be needed before you leave the practice.
We provide individual advice and the date for your check-up or next treatment. OCT helps determine the next interval.
Intravitreal injections are available at both Savignyplatz and Greifswalder Straße.
Outpatient surgery centre
Carmerstraße 7
10623 Berlin-Charlottenburg
Outpatient surgery unit
Greifswalder Straße 137–138
10409 Berlin-Pankow
Most symptoms are mild and settle quickly. Some changes, however, need attention before your next routine appointment.
Do not rub the eye. Keep water, dirt and cosmetics out of it during the first few days, and always follow your personal aftercare instructions.
Seek immediate assessment by an ophthalmologist. Do not wait for your next check-up. If we are unavailable, contact an eye hospital or the out-of-hours medical service on 116117; for a serious injury or a potentially life-threatening condition, call 112.
Guidance for urgent symptomsIntravitreal injections are among the most common eye procedures. Serious complications are rare, but need clear explanation and early recognition.
This list does not replace a personal discussion of the risks. Please tell us about recent vascular events, serious illnesses, pregnancy, allergies and all medicines you take.
Anaesthetic drops numb the eye’s surface beforehand. Many people feel brief pressure or touch rather than pain. Mild stinging or irritation may occur as the anaesthetic wears off.
The injection itself takes only a few seconds. Please allow considerably more time for registration, preparation, anaesthetic drops, sterile cleaning, treatment and the check afterwards. The exact arrangements may vary between appointments.
The effect is temporary, and the underlying condition may become active again. Regular checks and timely retreatment help preserve the result as well as possible.
Never change anticoagulants on your own. They often do not need to be stopped for an intravitreal injection, but your treating team decides according to your situation.
Disinfectant, small air bubbles or dilated pupils may affect your vision immediately after an intravitreal injection. Do not drive again until your vision has recovered sufficiently and you meet the legal requirements.
Treatment can control disease activity, reduce fluid and preserve or improve vision. Many underlying conditions remain chronic, however, and need long-term monitoring.
This page provides general information and cannot replace an eye examination. Whether an intravitreal injection is appropriate, which medicine to use and how often treatment is needed can only be decided after assessing your individual condition.
Book online, or contact a practice by phone or email using the details on our locations page.